Related Experiment Video
Updated: Jan 22, 2026

MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel
Borja Ibanez1, Anthony H Aletras2, Andrew E Arai3
1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; CIBERCV, Madrid, Spain; Cardiology Department, IIS Fundación Jiménez Díaz Hospital, Madrid, Spain.
Insights
Standardizing cardiac magnetic resonance (CMR) methods is crucial for evaluating cardioprotective strategies after myocardial infarction (MI). This consensus document recommends CMR endpoints based on pathophysiology to improve clinical trial translation and patient outcomes.
Area of Science:
- Cardiovascular Research
- Medical Imaging
- Translational Science
Background:
- Myocardial infarction (MI) triggers dynamic tissue changes impacting long-term prognosis.
- Cardiac magnetic resonance (CMR) is the gold standard for noninvasive myocardial tissue characterization and assessing cardioprotective strategies.
- Heterogeneity in CMR methodologies across trials hinders translation of findings into clinical practice.
Purpose of the Study:
- To provide expert recommendations for selecting standardized CMR endpoints in experimental and clinical trials.
- To align CMR endpoint selection with underlying pathophysiology and association with hard clinical outcomes.
- To improve the consistency and translational value of CMR in cardiovascular research.
Main Methods:
- A scientific expert panel convened to review current CMR methodologies in MI research.
- Recommendations were developed based on the pathophysiology of post-MI tissue changes.
- Emphasis was placed on linking CMR findings to hard clinical outcomes.
Main Results:
- Identified critical need for standardization in CMR acquisition protocols and endpoint selection.
- Proposed a framework for selecting CMR endpoints that reflect pathophysiological processes post-MI.
- Highlighted the importance of correlating CMR metrics with hard clinical outcomes.
Conclusions:
- Standardized CMR endpoints are essential for robust evaluation of cardioprotective therapies.
- Recommendations aim to enhance the reliability and clinical applicability of CMR in MI trials.
- Adoption of these guidelines will facilitate better translation of research findings to patient care.
Abstract:
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). The extension and magnitude of these changes contribute to long-term prognosis after MI. Cardiac magnetic resonance (CMR) is the gold-standard technique for noninvasive myocardial tissue characterization. CMR is also the preferred methodology for the identification of potential benefits associated with new cardioprotective strategies both in experimental and clinical trials. However, there is a wide heterogeneity in CMR methodologies used in experimental and clinical trials, including time of post-MI scan, acquisition protocols, and, more importantly, selection of endpoints. There is a need for standardization of these methodologies to improve the translation into a real clinical benefit. The main objective of this scientific expert panel consensus document is to provide recommendations for CMR endpoint selection in experimental and clinical trials based on pathophysiology and its association with hard outcomes.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
The Scientific Method
Statistical Software for Data Analysis and Clinical Trials

